ChromaTan, Inc

Please join us for our May 15th ChromaChats™ meeting "Purification Challenges for mRNA Production, Pt. 2”. ChromaTan ChromaChats™ • Topic: Purification Challenges for mRNA Production, Pt. 2 • Wednesday, May 15th | 7:00 am PT/10:00 am ET • Registration: https://lnkd.in/eYcrsuBq This mRNA-focused series of virtual roundtables features four industry thought leaders for discussions on the big four aspects of mRNA Production – upstream, downstream, analytical, and scale-up. Each panelist will give a 2-3-minute introduction followed by a Q&A and open group discussion. Panelists • Richard D. Braatz | Massachusetts Institute of Technology • Anna Senczuk | Seqirus • Zoltán Kis | The University of Sheffield • Jing Zhu, Ph.D. | Recipharm ChromaChats™ is a virtual gathering for bioprocessing leaders to connect and discuss shared challenges and interests. Attendees are encouraged to connect to extend their networks. There are no fees, NDAs, sponsors, or sales pitches. Just great people and great conversation. #chromachats #mrna #bioprocessing

ChromaTan, Inc is excited to announce a collaboration with Landmark Bio enabled through a grant by National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals). This funding will support the development of an intensified recombinant adeno-associated virus (rAAV) production process, advancing gene therapy manufacturing.   This collaboration leverages Landmark Bio’s expertise in viral vector process development, chemistry, manufacturing and controls (CMC), and GMP manufacturing and ChromaTan, Inc's proprietary BioRMB continuous purification technology.   Click here to read the full press release: https://lnkd.in/dh5Ep7f9   We look forward to working with Landmark Bio and contributing to the NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals mission and community!   #GeneTherapy #Manufacturing #NIIMBL #LandmarkBio #Chromatan #Innovation #Biopharmaceuticals

ChromaTan, Inc is excited to announce a collaboration with Landmark Bio enabled through a grant by National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals). This funding will support the development of an intensified recombinant adeno-associated virus (rAAV) production process, advancing gene therapy manufacturing.   This collaboration leverages Landmark Bio’s expertise in viral vector process development, chemistry, manufacturing and controls (CMC), and GMP manufacturing and ChromaTan, Inc's proprietary BioRMB continuous purification technology.   Click here to read the full press release: https://lnkd.in/dh5Ep7f9   We look forward to working with Landmark Bio and contributing to the NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals mission and community!   #GeneTherapy #Manufacturing #NIIMBL #LandmarkBio #Chromatan #Innovation #Biopharmaceuticals

Thanks to HansonWade for hosting the Viral Vector Process Development and Viral Vector Manufacturing Summit in Boston this week where our CEO, Oleg Shinkazh had the opportunity to present on the ChromaTan BioRMB system and it's advantages for AAV and Lenti purification.

Come join ChromaTan in Boston this Thursday and Friday at the Backbay Hilton for the Viral Vector Process Development and Manufacturing Summit.

Come out and join ChromaTan, Inc at the Hanson Wade Viral Vector PD & MFG Summit at the Hilton Backbay in Boston next Wednesday-Friday, Feb. 19th to 21st. Our CEO, Oleg Shinkazh, will be presenting on our BioRMB technology.

Get ready to shake off the cold with ChromaTan, Inc at the upcoming Viral Vector PD Summit, Feb. 19-21.

Meet Oleg Shinkazh, ChromaTan Chief Executive Officer, at Bullpen Cup on Monday, January 13 at 12:15 PM during JPM Week 2025 in San Francisco. #ChromaTan ChromaTan is focused on continuous purification and process intensification using their BioRMB technology. The technology utilizes a moving resin slurry to simultaneously purify a constant feed of product, resulting in a significant increase in productivity, improved recovery and higher purity. Golden Gate Yacht Club 12:15 PM | Oleg Shinkazh | ChromaTan, Inc Request an Invitation: https://lnkd.in/gBeEn-jw